Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Amphastar Pharmaceuticals Inc (AMPH) vs T-Rex 2X Inverse MSTR Daily Target ETF (MSTZ) Price & Performance

Amphastar Pharmaceuticals IncTrade
T-Rex 2X Inverse MSTR Daily Target ETFTrade

Price performance (Past 24H)

Key statistics

Amphastar Pharmaceuticals Inc vs T-Rex 2X Inverse MSTR Daily Target ETF — how do they compare? Amphastar Pharmaceuticals Inc trades at $20.39 (market cap $868.62M), while T-Rex 2X Inverse MSTR Daily Target ETF trades at $10.75. Which is the better fit depends on your goals.

AMPHMSTZ
Market Cap
$868.62M
Sector
HealthLeveraged / Inverse
52-Week High
$30.81$27.92
52-Week Low
$16.87$3.88
Enterprise Value
$1.27B

Returns comparison

Trailing returns across standard periods

About Amphastar Pharmaceuticals Inc

Amphastar is a specialty pharmaceutical company that develops and markets injectable, intranasal, and inhalation products. Its portfolio includes both complex generic drugs and proprietary delivery systems.

Read more on AMPH

About T-Rex 2X Inverse MSTR Daily Target ETF

MSTZ is a leveraged ETF that seeks daily investment results corresponding to 200% of the inverse (opposite) of the daily performance of the MicroStrategy Incorporated (MSTR) stock. It is designed as a tactical tool for experienced traders to take a bearish position on MSTR, a company known for its large Bitcoin holdings. Due to the effects of compounding and leverage, the ETF is intended to be held for a single day and is not suitable for long-term investment, as its performance over longer periods may significantly deviate from its stated daily objective.

Read more on MSTZ